Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Analysis of Liquidity Ratios
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Current Ratio since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Goodwill and Intangible Asset Disclosure
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The composition of goodwill and intangible assets exhibited notable shifts over the five-year period. Goodwill remained relatively stable from 2022 through 2025, consistently reported at US$1,088,000 thousand. However, significant changes were observed within the categories of intangible assets, particularly in-process research and development and other intangible assets.
- Goodwill
- Goodwill increased from US$1,002,200 thousand in 2021 to US$1,088,000 thousand in 2022 and remained constant through 2025. This suggests a period of acquisition activity concluded in 2022, with no subsequent material changes to recorded goodwill.
- In-process Research and Development
- In-process research and development increased substantially from US$400,000 thousand in 2021 to US$603,600 thousand in 2022, and held steady at that level through 2023. A significant decrease was then observed in 2025, falling to US$224,600 thousand. This reduction may indicate the completion or abandonment of certain research projects, or a reclassification of these assets.
- Marketed Products & Finite-Lived Intangible Assets
- Marketed products and finite-lived intangible assets, both gross and net, were first reported in 2023 at US$238,000 thousand and US$236,300 thousand respectively. The gross carrying amount increased slightly to US$245,700 thousand in 2024 and remained constant through 2025. Accumulated amortization increased from negative US$1,700 thousand in 2023 to negative US$23,400 thousand in 2024 and further to negative US$46,100 thousand in 2025, resulting in a corresponding decrease in the net carrying amount from US$236,300 thousand to US$199,600 thousand over the same period. This indicates the ongoing amortization of these assets.
- Assembled Workforce
- An assembled workforce intangible asset was first reported in 2024 at US$7,700 thousand and remained constant through 2025. The emergence of this asset suggests a recent recognition related to the value of the company’s workforce.
- Other Intangible Assets
- Other intangible assets exhibited a substantial increase from US$400,000 thousand in 2021 to US$603,600 thousand in 2022, and continued to rise to US$839,900 thousand in 2023. A slight decrease to US$825,900 thousand was observed in 2024, followed by a more significant decline to US$424,200 thousand in 2025. This volatility suggests active management or revaluation of these assets.
- Total Goodwill and Intangible Assets
- The aggregate value of goodwill and intangible assets increased from US$1,402,200 thousand in 2021 to US$1,691,600 thousand in 2022, peaking at US$1,927,900 thousand in 2023. A slight decrease to US$1,913,900 thousand occurred in 2024, followed by a more pronounced decrease to US$1,512,200 thousand in 2025. This overall trend reflects the combined impact of changes in the individual intangible asset categories.
The significant fluctuations in in-process research and development and other intangible assets warrant further investigation to understand the underlying drivers and potential implications for future financial performance.
Adjustments to Financial Statements: Removal of Goodwill
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The information presents a five-year trend of reported and adjusted total assets and shareholders’ equity. The adjustments appear to relate to the removal of goodwill and associated amortization, as evidenced by the consistent difference between the reported and adjusted figures. A general upward trend is observed in both reported and adjusted values for total assets and shareholders’ equity over the period, though some fluctuations are present.
- Total Assets Trend
- Reported total assets increased from US$13,432.5 million in 2021 to US$25,643.0 million in 2025. However, the rate of increase was not consistent. A significant increase occurred between 2021 and 2022 (US$4,718.4 million), followed by a smaller increase in 2023 (US$4,579.3 million). A slight decrease was noted in 2024 (US$100.0 million) before resuming an upward trend in 2025 (US$3,109.8 million). The adjusted total assets follow a similar pattern, consistently lower than the reported figures, indicating the impact of the goodwill adjustments.
- Shareholders’ Equity Trend
- Reported shareholders’ equity also demonstrates an overall upward trend, rising from US$10,100.0 million in 2021 to US$18,665.8 million in 2025. Similar to total assets, the growth rate varied annually. The largest increase occurred between 2021 and 2022 (US$3,812.7 million), with a subsequent increase between 2022 and 2023 (US$3,667.7 million). A decrease was observed in 2024 (US$1,171.0 million), followed by a recovery in 2025 (US$1,088.0 million). Adjusted shareholders’ equity mirrors this trend, consistently lower than the reported equity due to the adjustments.
- Impact of Adjustments
- The difference between reported and adjusted figures for both total assets and shareholders’ equity remains relatively stable across the five-year period. In 2021, the adjustment reduced total assets by US$902.2 million and shareholders’ equity by US$1,002.2 million. These differences persisted through 2025, with adjustments of US$1,088.0 million to total assets and US$1,088.0 million to shareholders’ equity. This suggests a consistent approach to removing goodwill from the financial statements.
The consistent adjustments indicate a deliberate effort to present a financial position excluding the impact of goodwill. The fluctuations in reported figures suggest underlying operational changes or other accounting events impacting asset and equity values, while the stable adjustments highlight the ongoing removal of goodwill.
Vertex Pharmaceuticals Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial metrics demonstrate a consistent pattern when goodwill is removed from the calculation. Generally, adjusted ratios are modestly higher than their reported counterparts, suggesting that goodwill impacts reported performance. Trends observed across the five-year period reveal some fluctuations, particularly in profitability ratios.
- Total Asset Turnover
- Reported total asset turnover decreased from 0.56 in 2021 to 0.43 in 2023, before recovering slightly to 0.49 in 2024 and remaining at 0.47 in 2025. The adjusted total asset turnover mirrors this trend, consistently exceeding the reported value, starting at 0.61 in 2021 and ending at 0.49 in 2025. The difference between reported and adjusted values suggests that the inclusion of goodwill reduces the efficiency with which assets are utilized, as measured by revenue generation.
- Financial Leverage
- Reported financial leverage remained relatively stable between 2021 and 2023, fluctuating around 1.3. It increased to 1.37 in 2024 and remained constant in 2025. The adjusted financial leverage shows a similar pattern, but with slightly higher values, indicating a marginally increased reliance on debt financing when goodwill is excluded from the asset base. The adjusted leverage increased from 1.37 in 2021 to 1.40 in 2024 and remained constant in 2025.
- Return on Equity (ROE)
- Reported ROE experienced volatility. It rose from 23.19% in 2021 to 23.88% in 2022, then declined to 20.59% in 2023, experienced a significant negative value of -3.26% in 2024, and recovered to 21.18% in 2025. The adjusted ROE follows a similar trajectory, consistently higher than the reported ROE, and also showing a negative value of -3.50% in 2024, before recovering to 22.49% in 2025. The consistent difference between reported and adjusted ROE suggests that goodwill impacts the calculation of equity returns.
- Return on Assets (ROA)
- Reported ROA followed a pattern similar to ROE, decreasing from 17.44% in 2021 to 15.92% in 2023, then dropping to -2.38% in 2024, and recovering to 15.42% in 2025. Adjusted ROA consistently exceeded the reported ROA, starting at 18.84% in 2021 and ending at 16.10% in 2025, with a negative value of -2.50% in 2024. The consistent difference between reported and adjusted ROA indicates that goodwill influences the calculation of asset returns.
In summary, removing goodwill consistently results in higher asset turnover, financial leverage, ROE, and ROA values. The negative ROE and ROA values in 2024 for both reported and adjusted metrics indicate a period of reduced profitability, despite the adjustments. The trends suggest that while goodwill does not fundamentally alter the direction of these ratios, it does impact their magnitude.
Vertex Pharmaceuticals Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Revenues ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Revenues ÷ Adjusted total assets
= ÷ =
The analysis reveals trends in total asset values and associated turnover ratios over a five-year period. Reported total assets demonstrate a consistent increase, while adjusted total assets follow a similar pattern, albeit at slightly lower values. The reported and adjusted total asset turnover ratios exhibit fluctuations, indicating changes in the efficiency with which assets are used to generate sales.
- Reported Total Assets
- Reported total assets increased from US$13.43 billion in 2021 to US$18.15 billion in 2022, representing a substantial rise. This growth continued to US$22.73 billion in 2023, before experiencing a slight decrease to US$22.53 billion in 2024. A further increase to US$25.64 billion is observed in 2025.
- Adjusted Total Assets
- Adjusted total assets mirrored the trend of reported total assets, beginning at US$12.43 billion in 2021 and rising to US$17.06 billion in 2022. The value increased to US$21.64 billion in 2023, decreased slightly to US$21.45 billion in 2024, and then increased to US$24.56 billion in 2025. The difference between reported and adjusted total assets remains relatively consistent across the observed period.
- Reported Total Asset Turnover
- The reported total asset turnover ratio decreased from 0.56 in 2021 to 0.49 in 2022. A further decline to 0.43 was noted in 2023, representing the lowest value in the observed period. The ratio recovered somewhat to 0.49 in 2024, followed by a slight decrease to 0.47 in 2025.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio followed a similar pattern to the reported ratio, starting at 0.61 in 2021 and decreasing to 0.52 in 2022. The ratio continued to decline to 0.46 in 2023, before increasing to 0.51 in 2024. A slight decrease to 0.49 is observed in 2025. The adjusted ratio consistently remains higher than the reported ratio, suggesting that excluding certain asset components results in a more favorable efficiency metric.
Overall, while asset values have generally increased, the asset turnover ratios suggest a decreasing trend in efficiency between 2021 and 2023, with a partial recovery in 2024. The slight decline in both turnover ratios in 2025 warrants further investigation to determine the underlying causes and potential implications.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= ÷ =
Analysis reveals trends in both reported and adjusted financial leverage over a five-year period. Reported total assets increased consistently from 2021 to 2023, experienced a slight decrease in 2024, and then increased again in 2025. A similar pattern is observed in reported shareholders’ equity, with growth through 2023, a decline in 2024, and subsequent growth in 2025. Adjusted total assets and adjusted shareholders’ equity mirror these trends, though the absolute values are lower due to the adjustments made. The reported financial leverage ratio exhibits relative stability, fluctuating between 1.29 and 1.37. Conversely, the adjusted financial leverage ratio demonstrates a more pronounced upward trend.
- Adjusted Financial Leverage Trend
- The adjusted financial leverage ratio increased from 1.37 in 2021 to 1.40 in both 2024 and 2025. This indicates a growing reliance on debt or other forms of financing relative to adjusted equity over the period. The consistent increase suggests a deliberate shift in the capital structure or a sustained need for external funding.
- Relationship Between Reported and Adjusted Leverage
- The adjusted financial leverage ratio is consistently higher than the reported financial leverage ratio across all observed years. This difference arises from the adjustments made to both total assets and shareholders’ equity. The nature of these adjustments, while not explicitly stated, likely involves the removal of items such as goodwill and intangible assets, which are included in the reported figures but excluded in the adjusted calculations. This suggests that the company’s leverage position is more conservative when considering only tangible assets and equity.
- Asset and Equity Growth
- Both reported and adjusted total assets grew substantially between 2021 and 2025, indicating overall expansion of the company’s resource base. The slight dip in both total assets and shareholders’ equity in 2024 warrants further investigation to determine the underlying cause, such as asset disposals, share repurchases, or changes in accounting policies. The subsequent recovery in 2025 suggests this was a temporary fluctuation.
- Reported Leverage Stability
- The relative stability of the reported financial leverage ratio, despite the growth in assets and equity, suggests a balanced approach to financing. The company appears to be managing its debt levels in line with its asset base, maintaining a consistent risk profile from a reported perspective.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net income (loss) ÷ Shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Net income (loss) ÷ Adjusted shareholders’ equity
= 100 × ÷ =
Shareholders’ equity, both reported and adjusted, demonstrates an overall increasing trend from 2021 through 2025. However, the rate of growth fluctuates, with a noticeable dip in reported shareholders’ equity in 2024. The adjusted shareholders’ equity exhibits a more consistent growth pattern, though it also reflects the decrease observed in the reported equity for 2024. Return on Equity (ROE), both reported and adjusted, shows variability over the five-year period.
- Reported Shareholders’ Equity
- Reported shareholders’ equity increased from US$10.1 billion in 2021 to US$13.9 billion in 2022, representing a substantial gain. Further growth occurred in 2023, reaching US$17.6 billion. A decrease was then observed in 2024, falling to US$16.4 billion, before recovering to US$18.7 billion in 2025. This suggests potential volatility impacting equity during 2024.
- Adjusted Shareholders’ Equity
- Adjusted shareholders’ equity follows a similar trajectory to reported equity, beginning at US$9.1 billion in 2021 and rising to US$12.8 billion in 2022. Growth continued through 2023, reaching US$16.5 billion, followed by a decline to US$15.3 billion in 2024. A subsequent increase to US$17.6 billion in 2025 is noted. The adjusted equity consistently remains lower than the reported equity throughout the period, indicating the impact of adjustments made to the equity calculation.
- Reported ROE
- Reported ROE began at 23.19% in 2021 and increased to 23.88% in 2022. A decrease to 20.59% occurred in 2023, followed by a significant decline to -3.26% in 2024. The ROE recovered to 21.18% in 2025, though it did not reach the levels observed in the earlier years. The negative ROE in 2024 is a significant outlier and warrants further investigation.
- Adjusted ROE
- Adjusted ROE mirrors the trend of reported ROE, starting at 25.74% in 2021 and rising to 25.90% in 2022. It decreased to 21.95% in 2023, then dropped to -3.50% in 2024. A recovery to 22.49% was observed in 2025. The adjusted ROE consistently exceeds the reported ROE, reflecting the impact of the equity adjustments. The negative ROE in 2024, similar to the reported ROE, is a key observation.
The negative ROE values in 2024 for both reported and adjusted metrics are particularly noteworthy. This suggests a substantial decrease in profitability relative to equity during that year. The subsequent recovery in 2025 indicates a potential return to more favorable performance, but the cause of the 2024 decline should be examined. The consistent difference between reported and adjusted ROE highlights the significance of the equity adjustments in assessing the company’s financial performance.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Net income (loss) ÷ Adjusted total assets
= 100 × ÷ =
The analysis reveals trends in reported and adjusted return on assets (ROA) alongside corresponding total asset figures over a five-year period. Reported total assets demonstrate a consistent increase from 2021 to 2023, followed by a slight decrease in 2024 and a subsequent increase in 2025. Adjusted total assets mirror this pattern, exhibiting similar growth and fluctuation. The ROA figures, both reported and adjusted, show a more complex dynamic.
- Reported ROA
- Reported ROA increased from 17.44% in 2021 to 18.30% in 2022, indicating improved profitability relative to reported assets. A decline followed in 2023 to 15.92%, and a significant drop occurred in 2024, resulting in a negative ROA of -2.38%. The ROA partially recovered in 2025, reaching 15.42%.
- Adjusted ROA
- Adjusted ROA also increased from 2021 to 2022, moving from 18.84% to 19.47%. Similar to the reported ROA, a decrease was observed in 2023, settling at 16.72%. The most substantial decline occurred in 2024, with the adjusted ROA falling to -2.50%. A modest recovery was noted in 2025, with the adjusted ROA reaching 16.10%.
The adjusted ROA consistently exceeds the reported ROA across all observed years. This suggests that the adjustments made to total assets positively impact the calculated return. The substantial decline in both reported and adjusted ROA in 2024 warrants further investigation, as it indicates a significant decrease in profitability relative to assets. The partial recovery in 2025 is a positive sign, but the ROA remains below the levels observed in 2021-2023. The consistent difference between reported and adjusted ROA highlights the importance of understanding the nature of the adjustments made to total assets when evaluating the company’s performance.
- Asset Trends
- The relatively stable adjusted asset base, despite fluctuations in reported assets, suggests that the adjustments primarily relate to items that do not significantly impact long-term asset value. The increase in both reported and adjusted assets in 2025, coupled with the ROA recovery, may indicate renewed investment and improved operational efficiency.